Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


24.04.2017

1 Arch Pediatr
2 Clin Infect Dis
1 J Immunol
3 J Infect Dis
2 J Virol
1 N Engl J Med
4 Pediatr Infect Dis J
1 PLoS Med
4 PLoS One
13 Vaccine
1 Virus Res
1 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Pediatr

  1. SORGE F, Minodier P, Velayudhan-Deschamps N
    [Autochthonous dengue].
    Arch Pediatr. 2016;23:1284-1290.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. SKOWRONSKI DM, Chambers C
    Pooling and the potential dilution of repeat influenza vaccination effects.
    Clin Infect Dis. 2017 Apr 19. doi: 10.1093.
    PubMed     Text format    

  3. SUN M, Li C, Xu W, Liao G, et al
    Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses.
    Clin Infect Dis. 2017 Apr 13. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Immunol

  4. PEPINI T, Pulichino AM, Carsillo T, Carlson AL, et al
    Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design.
    J Immunol. 2017 Apr 17. pii: 1601877. doi: 10.4049/jimmunol.1601877.
    PubMed     Text format     Abstract available


    J Infect Dis

  5. SCHNELL MJ
    Editorial to: 6-Month Safety Data of Ebola Zaire Vaccine (rVSVDeltaG-ZEBOV-GP) in a Phase III Double Blind, Placebo Controlled Randomized Study in Healthy Adults.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format    

  6. S NELSON EA, Steele AD
    Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format    

  7. BURNETT E, Jonesteller CL, Tate JE, Yen C, et al
    Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  8. ZHANG Z, Dong Z, Li J, Carr MJ, et al
    Protective efficacy of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection.
    J Virol. 2017 Apr 19. pii: JVI.00333-17. doi: 10.1128/JVI.00333.
    PubMed     Text format     Abstract available

  9. DI PILATO M, Mejias-Perez E, Sorzano COS, Esteban M, et al
    Distinct roles of vaccinia virus NF-kB inhibitor proteins A52, B15 and K7 in the immune response.
    J Virol. 2017 Apr 19. pii: JVI.00575-17. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


    N Engl J Med

  10. LEDGERWOOD JE, DeZure AD, Stanley DA, Coates EE, et al
    Chimpanzee Adenovirus Vector Ebola Vaccine.
    N Engl J Med. 2017;376:928-938.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  11. VAN DER LEE S, Kemmeren JM, de Rond LGH, Ozturk K, et al
    Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination.
    Pediatr Infect Dis J. 2017 Apr 19. doi: 10.1097/INF.0000000000001620.
    PubMed     Text format     Abstract available

  12. DUBISCHAR KL, Kadlecek V, Sablan B Jr, Borja-Tabora CF, et al
    Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO(R) n Children from a Japanese Encephalitis Virus -Endemic Region.
    Pediatr Infect Dis J. 2017 Apr 19. doi: 10.1097/INF.0000000000001615.
    PubMed     Text format     Abstract available

  13. RIISE OR, Laake I, Vestrheim D, Flem E, et al
    Risk of Pertussis in Relation to Degree of Prematurity in Children Less Than 2 Years of Age.
    Pediatr Infect Dis J. 2017;36:e151-e156.
    PubMed     Text format     Abstract available

  14. HENAFF F, Levy C, Cohen R, Picard C, et al
    Risk Factors in Children Older Than 5 Years With Pneumococcal Meningitis: Data From a National Network.
    Pediatr Infect Dis J. 2017;36:457-461.
    PubMed     Text format     Abstract available


    PLoS Med

  15. ZAMAN K, Sack DA, Neuzil KM, Yunus M, et al
    Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.
    PLoS Med. 2017;14:e1002282.
    PubMed     Text format     Abstract available


    PLoS One

  16. GRANDAHL M, Larsson M, Tyden T, Stenhammar C, et al
    School nurses' attitudes towards and experiences of the Swedish school-based HPV vaccination programme - A repeated cross sectional study.
    PLoS One. 2017;12:e0175883.
    PubMed     Text format     Abstract available

  17. GASPARINHO C, Piedade J, Mirante MC, Mendes C, et al
    Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction.
    PLoS One. 2017;12:e0176046.
    PubMed     Text format     Abstract available

  18. VERMA S, Soto J, Vasudevan A, Schmeisser F, et al
    Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    PLoS One. 2017;12:e0175733.
    PubMed     Text format     Abstract available

  19. KREIZINGER Z, Sulyok KM, Grozner D, Beko K, et al
    Development of mismatch amplification mutation assays for the differentiation of MS1 vaccine strain from wild-type Mycoplasma synoviae and MS-H vaccine strains.
    PLoS One. 2017;12:e0175969.
    PubMed     Text format     Abstract available


    Vaccine

  20. MULLER T, Becker E, Stallmann S, Waldhuber A, et al
    Vaccination with the polymorphic membrane protein a reduces Chlamydia muridarum induced genital tract pathology.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30481.
    PubMed     Text format     Abstract available


  21. Tetanus vaccines: WHO position paper, February 2017 - Recommendations.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30228.
    PubMed     Text format     Abstract available

  22. LOZE PM, Nasciben LB, Sartori AMC, Itria A, et al
    Vaccines are different: A systematic review of budget impact analyses of vaccines.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30440.
    PubMed     Text format     Abstract available

  23. SUH J, Kim B, Yang Y, Suh DC, et al
    Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30480.
    PubMed     Text format     Abstract available

  24. HUIJTS SM, van Werkhoven CH, Bolkenbaas M, Grobbee DE, et al
    Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30151.
    PubMed     Text format     Abstract available

  25. GUO N, Zhang G, Zhu D, Wang J, et al
    The effects of convenience and quality on the demand for vaccination: Results from a discrete choice experiment.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30466.
    PubMed     Text format     Abstract available

  26. BERLANDA SCORZA F
    Advancing new vaccines against pandemic influenza in low-resource countries.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30446.
    PubMed     Text format     Abstract available

  27. ZANGENAH S, Bjorkhem-Bergman L, Norlin AC, Hansen S, et al
    The Pneumocell-study: Vaccination of IgG1- and IgG2-deficient patients with Prevnar13.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30449.
    PubMed     Text format     Abstract available

  28. EILERS R, de Melker HE, Veldwijk J, Krabbe PFM, et al
    Vaccine preferences and acceptance of older adults.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30478.
    PubMed     Text format     Abstract available

  29. GROOT N, Pileggi G, Sandoval CB, Grein I, et al
    Original article: Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30479.
    PubMed     Text format     Abstract available

  30. VAN DOORN E, Darvishian M, Dijkstra F, Donker GA, et al
    Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30476.
    PubMed     Text format     Abstract available

  31. SMITH TRF, Schultheis K, Morrow MP, Kraynyak KA, et al
    Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30468.
    PubMed     Text format     Abstract available

  32. DAUNER A, Agrawal P, Salvatico J, Tapia T, et al
    The in vitro MIMIC(R) platform reflects age-associated changes in immunological responses after influenza vaccination.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30451.
    PubMed     Text format     Abstract available


    Virus Res

  33. FULTON RW, Neill JD, Saliki JT, Landis C, et al
    Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
    Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  34. Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC): summary of conclusions and recommendations, 1-2 February 2017 meeting.
    Wkly Epidemiol Rec. 2017;92:181-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: